01 Oct 2009
A recent case found that a generic pharmaceutical company can use the name of a branded drug in comparative advertising in France. Philippe Lods of Lavoix examines how branded pharmaceutical companies can defend themselves
November / December 2019
IP law: are the pressures taking their toll?
Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2019 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International